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INTRODUCTION 
Diabetes is a disease which affects 150 million  individuals1 world wide. Diabetes 
mellitus (DM) has long been recognized as a major public health problem1 with far 
reaching consequences, not only for its adverse health impact on individuals, but also for 
its economic burden on the health care system and the society at large . The International 
Diabetes Federation (IDF) in 2005 confirmed that diabetes is one of the most common 
non-communicable diseases globally2 and constitutes the fourth or fifth leading cause of 
death in most developed countries as well as many developing and newly industrialized 
countries. In India, over 30 million people have been diagnosed with pre-diabetes.Pre-
diabetes is a condition in which the glucose levels are higher than normal but enough for 
the diagnosis of diabetes mellitus .The microvascular complications starts in  the pre-
diabetic state itself so early diagnosis and treatment  of this condition is important as this 
delay the progression of microvascular complications and onset of diabetes mellitus. As 
far as the pre-diabetic population is concerned, only China surpasses India, and by 
2025,every fifth diabetic in the world will be an Indian.Pre-diabetes is a mounting 
problem in India. The prevalence of IGT is thought to be around 8.7 per cent in urban 
areas and 7.9 per cent in rural areas. It is thought that around 35 per cent of IGT 
sufferers go on to develop Type 2 diabetes. So, India is genuinely facing a healthcare 
crisis and the type of diabetes that its people suffer from differs considerably from what 
patients in the West suffer from. Pre-diabetes currently refers to people who have 
impaired fasting glucose (IFG) i. e. fasting glucose levels between 100- 125mg/dl or 
impaired glucose tolerance (IGT), i. e. two hours post glucose load between 140-199mg/
dl or both. Pre-diabetes raises short-term absolute risk of Type 2 diabetes five to six 
fold, and in some populations this maybe even higher3. People with diabetes are 
vulnerable to multiple and complex medical complications. These complications involve 
both cardiovascular disease (heart disease, stroke) and microvascular disease. 
Epidemiologic evidence suggests that these complications of diabetes begin early in the 
progression from normal glucose tolerance to frank diabetes4. Early identification and 
treatment of persons with pre-diabetic conditions has the potential   reduce  both  the 
incidence of diabetes and related complications.. Early diabetic nephropathy in the pre-
diabetic state can be detected by micro-albuminuriaand retinopathy by typical 
funduschanges.
Recognition of microalbuminuria Stemmed from Diabetes research  decades 
ago.According to National Kidney Foundation Microalbuminuria          is defined as a 
Urine Albumin Excretion Rate (UAER) of approximately 30-300mg/d in atleast two of 
three consecutive samples of nonketotic sterile urine. . Microalbuminuria 5possibly 
reflects a state of increased renal endothelial permeability and is an easily measured 
marker of rather diffuse endothelial dysfunction, low grade inflammation and vascular 
disease burden.   There are data supporting that this programme would have beneficial 
effects in detecting individuals at high risk for cardiovascular atherosclerotic disease. 
Regarding the determination of microalbuminuria, there had been considerable variation 
in the performance of diagnostic tests.  24 hour urine albumin excretion remains the gold 
standard, but impractical for routine practice.  Microalbuminuria can be diagnosed on 
the basis of three positive tests – Albumin creatinine ratio; urine albumin excretion rate 
or a combination of both
Almost 8% of individuals with pre-diabetes have detectable early diabetic retinopathy, 
according to research presented June 12 at the 65th Scientific Sessions of the American 
Diabetes Association (ADA) in San Diego. 
Among those with very early diabetes (diagnosis within 6 to 12 months of the onset of 
diabetes), almost 13% have diabetic retinopathy, investigators found. ADA's chief 
scientific and medical officer, Richard Kahn, PhD, says the the complications of 
diabetes begin years before a typical diagnosis
Finally, the appearance of retinopathy in patients with pre-diabetes, and the suggestion 
that lesions are present at glucose levels below the current diagnostic thresholds for 
diabetes, could lead experts to reconsider those limits   
        . 
   
                        AIMS AND OBJECTIVES
1. To  study  the  relative  frequency  of  microalbumiuria  and  retinopathy  in   pre-
diabetic individuals.
2. To study the correlation between blood sugar levels and microalbuminuria.
3. To  study  the  correlation  between  blood  sugar  levels  and  retinopathy  in  pre-
diabetics.
4. To  study  the  correlation  between  microalbuminuria  and  retinopathy  in  pre-
diabetics.
 
REVIEW OF LITERATURE
The term pre-diabetes  include population whose blood  sugar is higher than normal but 
not enough for the diagnosis of diabetes .
Defining Pre-diabetes:
.  The American diabetic association defined pre-diabetes as condition in which fasting 
blood sugar {FBS} between 100-125mg/dl or two hour postprandial blood sugar {2hr 
PPBS} between 140-199mg/dl or both. 
Symptoms of Pre-diabetes
Although most people with pre-diabetes have no symptoms at all, symptoms of diabetes 
may  include  unusual  thirst,  a  frequent  desire  to  urinate,  blurred  vision,  or  extreme 
fatigue.
Screening for Pre-diabetes6
1.over 45 years of age 
2. have any risk factors for diabetes 
3. overweight with a BMI (body mass index) over 25 
4. belong to a high risk ethnic group 
5.have a history of gestational diabetes or delivering a baby that weight more than  9 lbs 
6.You have high triglycerides and low HDL cholesterol, central obesity and 
hypertension (the metabolic insulin resistance syndrome).
Pathophysiology of Pre-Diabetes
Substantial defects in insulin secretion have been noted inpatients with IFG and 
IGT.Elevated plasma glucose 2 h postchallenge 7predicts defects in beta-cell function. 
Defective Insulin secretion have been demonstrated in people with normal fasting 
glucose and glycosylated hemoglobin concentrations with glucose values greater than 
140 mg/dL or 7.8 mmol/L 2 hours after ingestion of 75 g of glucose orally. Thus, defects 
in insulin secretion8 can be detected before the onset of overt hyperglycemia. Detailed 
study of insulin secretion in patients with IGT has demonstrated that consistent 
quantitative and qualitative defects are seen in this group. During oral glucose tolerance 
testing, there is a delay in the peak insulin response and first-phase insulin responses to 
an intravenous glucose bolus are consistently decreased in relation to ambient insulin 
sensitivity. Further, abnormalities in first-phase insulin secretion were observed in first-
degree relatives of patients with type 2 diabetes who exhibited only mild intolerance to 
glucose, and an attenuated insulin response to oral glucose was observed in 
normoglycemic co-twins of patients with type 2 diabetes. This pattern of insulin 
secretion during the so-called prediabetic phase was also seen in subjects with IGT who 
later developed type 2 diabetes and in normoglycemic obese subjects with a recent 
history of gestational diabetes, another group at high risk for type 2 diabetes.Beta cell 
abnormalities may therefore precede the development of overt type 2 diabetes by many 
years.
The temporal pattern of insulin secretory responses is altered in IGT and is similar to but 
not as pronounced as that seen in diabetic subjects . There is a loss of coordinated 
insulin secretory responses during oscillatory glucose infusion, indicating that the ability 
of the beta cell to sense and respond appropriately to parallel changes in the plasma 
glucose level is impaired.  Abnormalities in rapid oscillations of insulin secretion have 
also been observed in first-degree relatives of patients with type 2 diabetes who have 
only mild glucose intolerance,further suggesting that abnormalities in the temporal 
pattern of beta cell function may be an early manifestation of beta cell dysfunction 
preceding the development of type 2 diabetes. Because an elevation in serum proinsulin 
is seen in subjects with diabetes, the contribution of proinsulin to the hyperinsulinemia 
of IGT has been questioned. The hyperinsulinemia9 of IGT has not been accounted 
 by an increase in proinsulin, although elevations in fasting and stimulated proinsulin or 
proinsulin/insulin ratios have been found by many, although not all, investigators. 
Correlation of elevated proinsulin levels in IGT as a predictor of future conversion to 
diabetes has also been observed. 
Obesity and other insulin-resistant states are associated with a substantially greater risk 
for the development of type 2 diabetes. The ability of the pancreatic beta cell to 
compensate for insulin resistance determines whether blood glucose levels remain 
normal in insulin-resistant subjects or whether the subjects develop glucose intolerance 
or diabetes. Kahn and co-workers studied the relationship between insulin sensitivity 
and beta cell function in 93 relatively young, apparently healthy human subjects of 
varying degrees of obesity.  In human with normal glucose tolerance and varying 
degrees of obesity, beta cell function varies quantitatively with differences in insulin 
sensitivity. 
The insulin resistance of obesity is characterized by hyperinsulinemia. Hyperinsulinemia 
in this setting reflects a combination of increased insulin production and decreased 
insulin clearance, but most evidence suggests that increased insulin secretion is the 
predominant factor. Both basal and 24-hour insulin secretory rates are three to four times 
higher in obese subjects and are strongly correlated with body mass index.
THE ROLE OF INCREASED HEPATIC GLUCOSE PRODUCTION IN 
IMPAIRED GLUCOSE TOLERANCE.
The disposal of glucose after meals depends on the ability of insulin to increase 
peripheral glucose uptake and simultaneously decrease endogenous glucose production. 
Although studies have suggested that the kidney can contribute up to 25% of 
endogenous glucose production,the defect in type 2 diabetes is primarily in defective 
regulation of glucose production from the liver . Two routes of glucose production by 
the liver are  glycogenolysis  of stored glycogen and gluconeogenesis from two- and 
three-carbon substrates derived primarily from skeletalmuscle. .The production of 
glucose by the liver is regulated primarily by the relative actions of glucagon and insulin 
to activate or suppress glucose production, respectively, although the nervous system 
and glucose autoregulation of hepatic glucose production probably play less important 
roles. The ability of insulin to reduce HGO is an important mechanism for maintaining 
normal glucose tolerance. Under normal circumstances, insulin suppresses up to 85% of 
glucose production in normal individuals by directly inhibiting glycogenolysis, 
especially at lower insulin concentrations.Under circumstances in which glycogenolysis 
is enhanced by glucagon, the effects of insulin to suppress hepatic glucose production 
may be even greater. Glucagon increases glycogenolysis by activation of the classical 
protein kinase cascade involving cyclic AMP (cAMP)dependent protein kinase and 
phosphorylase10 and also increases gluconeogenesis in part by increasing the 
transcription of phosphoenolpyruvate carboxykinase through the cAMP response 
element binding protein. 
The indirect or peripheral effect of insulin in controlling glucose production by the liver 
is twofold. First, insulin has a profound effect on decreasing glucagon secretion by the 
alpha cell of the pancreas through systemic and paracrine effects. The decrease in 
glucagon secretion decreases the activation of glycogenolysis and gluconeogenesis. The 
second important peripheral action of insulin is decreasing FFA levels by suppressing 
lipolysis. FFAs11 increase hepatic glucose production by stimulating 
gluconeogenesis.The suppression of glucagon secretion and decrease in FFA delivery12 
to the liver are additive in reducing liver glucose production. 
Hepatic insulin resistance plays an important role in the hyperglycemia of type 2 
diabetes,and the impairment in suppression of HGO appears to be quantitatively similar 
to or even larger than the defect in the stimulation of peripheral glucose disposal. There 
is a direct relationship between increases in HGO and fasting hyperglycemia . Treatment 
of patients with metformin, which suppress hepatic glucose production, results in 
improvements in glucose tolerance.
 
Complications of  Pre- Diabetes
Pre-Diabetes  are characterized by hyperglycemia13, a relative deficiency of insulin, and 
the development of diabetes-specific microvascular pathology in the retina, renal 
glomerulus, and peripheral nerve. Pre-diabetes is also associated with accelerated 
atherosclerotic macrovascular disease affecting arteries that supply the heart, brain, and 
lower extremities.Large, prospective clinical studies show a strong relationship between 
glycemia and diabetic microvascular complications . There is a continuous, though not 
linear, relationship between level of glycemia and the risk of development and 
progression of these complications   Hyperglycemia and the dyslipidemia induced by 
insulin resistance both appear to play important roles in the pathogenesis of 
macrovascular complications.
SHARED PATHOPHYSIOLOGIC FEATURES OF MICROVASCULAR 
COMPLICATIONS
In the retina, glomerulus, and vasa nervorum, diabetes-specific microvascular disease is 
characterized by similar pathophysiologic features.
1.Requirement for Intracellular Hyperglycemia
Clinical  data indicate that chronic hyperglycemia is the central initiating factor for all 
types of diabetic microvascular disease. Duration and magnitude of hyperglycemia are 
both strongly correlated with the extent and rate of progression of diabetic microvascular 
disease.  Although all diabetic cells are exposed to elevated levels of plasma glucose, 
hyperglycemic damage is limited to those cell types (e.g., endothelial cells) that develop 
intracellular hyperglycemia. Endothelial cells develop intracellular hyperglycemia 
because, unlike many other cells, they cannot down-regulate glucose transport 16when 
exposed to extracellular hyperglycemia.  vascular smooth muscle cells, which are not 
damaged by hyperglycemia, show an inverse relationship between extracellular glucose 
concentration17 and subsequent rate of glucose transport  . In contrast, vascular 
endothelial cells show no significant change in subsequent rate of glucose transport after 
exposure to elevated glucose concentrations.
2.Abnormal Endothelial Cell Function
Early in the course of diabetes mellitus, before structural changes are evident, 
hyperglycemia causes abnormalities in blood flow and vascular permeability in the 
retina, glomerulus, and peripheral nerve vasa nervorum. The increase in blood flow and 
intracapillary pressure is thought to reflect hyperglycemia-induced decreased nitric 
oxide (NO) production18 on the efferent side of capillary beds, and possibly an increased 
sensitivity to angiotensin II. As a consequence of increased intracapillary pressure and 
endothelial cell dysfunction, retinal capillaries exhibit increased leakage of fluorescein 
and glomerular capillaries have an elevated albumin excretion rate (AER). Comparable 
changes occur in the vasa vasorum of peripheral nerve. Early in the course of diabetes, 
increased permeability is reversible; as time progresses, however, it becomes 
irreversible.
3.Increased Vessel Wall Protein Accumulation
The common pathophysiologic feature of diabetic microvascular disease is progressive 
narrowing and eventual occlusion of vascular lumina, which results in inadequate 
perfusion and function of the affected tissues. Early hyperglycemia-induced 
microvascular hypertension and increased vascular permeability contribute to 
irreversible microvessel occlusion by three processes:
The first is an abnormal leakage of periodic acidSchiff (PAS)-positive, carbohydrate-
containing plasma proteins, which are deposited in the capillary wall and which may 
stimulate perivascular cells such as pericytes and mesangial cells to elaborate growth 
factors and extracellular matrix.
The second is extravasation of growth factors, such as transforming growth factor 1 
(TGF-1 ), which directly stimulates overproduction of extracellular matrix components, 
and may induce apoptosis in certain complication-relevant cell types.
The third is hypertension-induced stimulation of pathologic gene expression by 
endothelial cells and supporting cells, which include glut-1 glucose transporters, growth 
factors, growth factor receptors, extracellular matrix components, and adhesion 
molecules that can activate circulating leukocytes.The observation that unilateral 
reduction in the severity of diabetic microvascular disease occurs on the side with 
ophthalmic or renal artery stenosis is consistent with this concept.
Microvascular Cell Loss and Vessel Occlusion
The progressive narrowing and occlusion of diabetic microvascular lumina are also 
accompanied by microvascular cell loss. In the retina, diabetes mellitus induces 
programmed cell death of Müller cells and ganglion cells, pericytes, and endothelial 
cells.In the glomerulus, declining renal function is associated with widespread capillary 
occlusion and podocyte loss, but the mechanisms underlying glomerular cell loss are not 
yet known. In the vasa nervorum, endothelial cell and pericyte degeneration occur, and 
these microvascular complication.
4.Development of Microvascular Complications During Posthyperglycemic 
Euglycemia ("Hyperglycemic Memory)
Another common feature of diabetic microvascular disease has been termed 
hyperglycemic memory, or the persistence or progression of hyperglycemia-induced 
microvascular alterations during subsequent periods of normal glucose homeostasis. 
Hyperglycemia-induced increases in selected matrix gene transcription also persist for 
weeks after restoration of normoglycemia in vivo, and a less pronounced, but 
qualitatively similar, prolongation of hyperglycemia-induced increase in selected matrix 
gene transcription occurs in cultured endothelial cells.
 Observations from clinical studies imply that hyperglycemia induces prolonged and 
sometimes irreversible changes in long-lived intracellular molecules that persist and 
cause continued pathologic function in the absence of continued hyperglycemia. 
5.Genetic Determinants of Susceptibility to Microvascular Complications
Clinicians have long observed that different patients with similar duration and degree of 
hyperglycemia differed markedly in their susceptibility to microvascular complications. 
Such observations suggested that genetic differences existed that affected the pathways 
by which hyperglycemia damaged microvascular cells. 
A role for genetic determinant of susceptibility to diabetic nephropathy is most strongly 
supported by the demonstration of familial clustering of diabetic nephropathy. 
MECHANISMS OF HYPERGLYCEMIA-INDUCED DAMAGE
Four major hypotheses about how hyperglycemia causes diabetic complications have 
generated a large amount of data as
well as several clinical trials based on specific inhibitors of these mechanisms. Until 
recently, there was no unifying hypothesis linking these four mechanisms together, nor 
was there an obvious connection between any of these mechanisms, each of which 
responds quickly to normalization of hyperglycemia, and the phenomenon of 
hyperglycemic memory . Increased Polyol Pathway Flux,Aldose Reductase Function.
Advanced Glycation End-Product Inhibitors19
The hydrazine compound aminoguanidine was the first AGE inhibitor discovered.  In a 
large randomized, double-blind, placebo-controlled, multicenter trial , Aminoguanidine20 
reduced the progression of diabetic retinopathy (defined as an increase by three or more 
steps in the Early Treatment Diabetic Retinopathy Study).
Future Drug Targets
The recent discovery that each of the four different pathogenic mechanisms discussed in 
this section reflect a single hyperglycemia-induced process  suggests that interrupting 
the overproduction of superoxide by the mitochondrial electron transport chain would 
normalize polyol pathway flux, AGE formation, PKC activation, hexosamine pathway 
flux, and NF-B activation. Novel compounds that act as superoxide dismutase/catalase 
mimetics already exist,and these compounds have been shown to normalize 
hyperglycemia-induced mitochondrial superoxide overproduction. These and the other 
agents described in this section may have unique clinical efficacy in preventing the 
development and progression of diabetic complications.
RETINOPATHY, MACULAR EDEMA, AND OTHER OCULAR 
COMPLICATIONS.
Diabetic retinopathy is a well-characterized, sight-threatening, chronic microvascular 
complication that eventually afflicts virtually all patients with diabetes mellitus.Diabetic 
retinopathy is characterized by gradually progressive alterations in the retinal 
microvasculature, leading to areas of retinal nonperfusion, increased vasopermeability, 
and pathologic intraocular proliferation of retinal vessels.Epidemiological studies have 
shown that early retinopathy changes are seen in pre-diabetic patients.A study of 
retinopathy in pre-diabetes ,published in 65th ADA scientific sessions showed a 
prevalence of 8% compared to 13% in early diabetes. The complications associated with 
the increased vasopermeability, termed macular edema, and uncontrolled 
neovascularization, termed proliferative diabetic retinopathy (PDR), can result in severe 
and permanent visual loss. The retinopathy in diabetic patients can be divided into Non-
proliferative diabetic retinopathy(Mild,Mod,Severe),proliferative diabetic retinopathy 
and Cystoid macular oedema.
NEPHROPATHY IN DIABETES AND PRE-DIABETES
 The development of proteinuria in patients with diabetes mellitus has been described in 
the eighteenth century by Cotugno and it was Richard Bright who postulated in 1836 
that albuminuria reflects renal disease. There is now consensus that a lowish but 
supranormal albumin excretion rate in the urine('microalbuminuria') is a powerful 
predictor of renal (and cardiovascular) events ( Parving  et al  . 1982  ). Persistent 
albuminuria, that is, greater than 300 mg/24 h or 200 μg/min, is the clinical hallmark of 
the manifestation of diabetic nephropathy (DN). .  
PATHOMECHANISMS FOR MICROVASCULAR DAMAGE         The microvascular 
lesions 21of the kidney in diabetes mellitus had variably been ascribed to generation of 
advanced glycation endproducts (AGE)22, cumulation of sorbitol, activation of protein 
kinase C (PKC), and activation of the hexosamine pathway. A unifying concept has 
recently been proposed byBrown Lee. He provided evidence that in insulin-insensitive 
tissues hyperglycaemia increases the delivery of glucose-derived intermediates as the 
metabolic substrate for mitochondrial oxidation. Increased mitochondrial oxidation leads 
to the generation of reactive oxygen species (ROS). ROS are responsible for the 
following four metabolic abnormalities: (a) accumulation of methylglyoxal and other 
substrates leads to the generation of early Amadori products and Advanced Glycosylated 
End products (b) furthermore activation of PKC by ROS, particularly the β-isoenzyme, 
(c) activation of the polyol pathway causing accumulation of sorbitol, and finally (d) 
also activation of the hexosamine pathway. 
Major attention has recently been paid to the pathogenic role of AGE.  Glucose 
interact with the α and γ amino groups of amino acids to form Schiff bases that 
rearrange spontaneously to yield Amadori products. These are non-enzymatically 
transformed into highly reactive early Amadori products, for example, methylglyoxal, 
dideoxyglucosone, deoxyglucosone, etc. In the course of weeks, heterocyclic advanced 
fluorescent AGEs are generated, which cross-link proteins and interact with several 
receptors, the most important of which is receptor for AGE (RAGE).Activation of the 
RAGE23 triggers ROS formation and promotes translocation of the transcription factor 
NF-κB, a central switch for inflammatory processes into the nucleus.Important 
secondary mediators for the development of renal damage are transforming growth 
factor β (TGFβ) , locally generated angiotensin II, endothelin, and several other 
cytokines.  Glomerular hypertension resulting from afferent vasodilatation and efferent 
vasoconstriction, in conjunction with altered glomerular permeability causes 
proteinuria24 activation of proximal tubular epithelial cells, renal fibrosis and ultimately 
nephron loss and renal failure.  
Apart from elevated systemic and glomerular capillary pressure, proteinuria plays a 
major pathogenetic role. Remuzzi  et al  . (2002)  had postulated that proteinuria is not 
only a marker of adverse renal prognosis, but actually a 'nephrotoxin'. This concept has 
been amply confirmed by studies showing that proximal tubular epithelial cells acquire 
an inflammatory phenotype and upregulate expression of angiotensinogen , endothelin , 
and cytokines, when they have been confronted with a protein overload in the tubular 
fluid. Albumin was shown to be less injurious than complement factors, iron-containing 
proteins and oxidized lipids  Angiotensin II, endothelin, and cytokines are then secreted 
i into the interstitium where they activate peritubular fibroblasts and lead to interstitial 
fibrosis..Mechanism of microalbuminuria and proteinuria.                             
In the past, it had been thought that negatively charged molecules of the GBM are 
reduced, particularly sialic acid and heparan sulfate, normally repel negatively charged 
anionic albumin. As a result glomerular permselectivity would be reduced so that 
albumin molecules can escape into the glomerular filtrate. Reduced negative charge 
density of the GBM has not been consistently confirmed ( van den Born  et al  . 1995   ). 
It was also thought that in later stages of DN, disruption of the texture of the basal 
membrane creates gaps and holes  and allows high molecular weight serum proteins to 
escape into the filtrate.Recent insights into podocyte function and specifically 
identification of proteins of the slit membrane ( Mundel and Shankland 2002 ) have 
led to the concept that the podocyte is a prime player in the genesis of proteinuria.. It is 
also of interest that in experimental diabetes, podocyte damage is the first sign of renal 
injury ( Gross  et al  . 2003  ). Diminished podocyte numbers have been documented in 
animals and patients with diabetes ( Steffes  et al  . 2001   ). Podocytes are postmitotic and 
can no longer proliferate.  
Stages of diabetic nephropathy 
There are few renal diseases where the course is as predictable as in DN. This has led to 
a scheme proposed by Mogensen  which is valid in type 1 diabetes, but less consistently 
so in type 2 diabetes. An early stage of renal hyperfunction is followed by a stage of 
clinical latency which may last up to 20 years. It is subsequently followed in a very 
well-defined time course by the stages of microalbuminuria progressing to that of overt 
nephropathy and renal failure. 
 The stages of diabetic nephropathy 
Stages 
Glomerular 
filtration 
Albuminuria 
Bloodpressure
 
Time 
interval  
1.Renal hyperfunction Elevated Absent Normal At 
diagnosis 
2.Clinical latency High 
normal 
Absent 
3.Microalbuminuria Within 
the normal 
range 
20–200 
μg/min (30–
300 mg/day) 
Rising 
within or 
above the 
normal range 
5–15yrs 
4.Macroalbuminuria/proteinur
ia (overt nephropathy) 
Decreasing 200 
μg/min (300 
mg/day) 
Increased 10–15yrs 
Renal failure Diminished Massive Increased 15–30 
The  factors that increase the risk to develop diabetic nephropathy are;
1.Hyperglycemia.
2.Smoking.
3.Hypertension. 
Obviously there is no DN without hyperglycaemia. The role of hyperglycaemia in the 
development of DN is most convincingly demonstrated by transplantation studies. When 
normal kidneys are transplanted into diabetic recipients, they developed 
glomerulosclerosis in experimental or clinical observations ( Mauer et al . 1976 ). More 
excitingly isolated pancreatic transplantation in patients with type 1 diabetes and 
nephropathy led gradually after several years to the regression of diabetic 
glomerulosclerosis ( Fioretto et al . 1998 ). There exists a wealth of information on the 
association between hyperglycaemia or HbA1c concentrations and development of 
microalbuminuria ( Prirart 1978 ; Feldt-Rasmussen and Deckert 1993 ; Krolewski et al . 
1996 ; Rudberg and Dahlquist 1996 ). The definite proof that the association is causal in 
nature has come from intervention trials, that is, the Diabetes Control and Complications 
Trial (DCCT) ( The Diabetes Control and Complications Trial Research Group 1993 ) in 
type 1 diabetes and the Kumamoto trial (Shichiri et al . 1995) as well as the UKPDS 
study ( UK Prospective Diabetes Study Group 1998 ) in type 2 diabetes . 
MICROALBUMINURIA
Concepts and definition:
The Invention of sensitive immunoassays in the beginning of 1960s allowed the 
measurement of previously undetectable amounts of albumin in urine. This is important 
because  microalbuminuria  is  now documented  and widely  accepted  as  an  important 
marker  for  early  diabetic  renal  disease,  and  also  of  early  vascular  complications 
including  early  mortality.   Recently  clear  treatment  strategies  based  upon  many 
intervention  trials  were  proposed.These  are  now  well  accepted  by  the  medical 
community.  Therefore screening for microalbuminuria and follow up of  patients is now 
general practice in some countries.  
Microalbuminuria is defined as UAER of approximately 30 – 300 mg/d (24 hour 
urine albumin excretion rate) in at least two of three consecutive samples of nonketonic 
sterile urine.  Ideal is the first voided, mid stream morning sample (5ml sample).  
ADA and NKF (American Diabetes Association and National Kidney Foudation) 
define microalbuminuria as an albumin creatinine ratio between 30 – 300 µg/mg in both 
men and women7.   Sex specific ACR cutpoints:  > 17  µg/mg in men, >25  µg/mg in 
women.  
24 hour urine albumin excretion rate: 30 – 300 mg/d. 
 Overnight urine albumin excretion rates: 20 - 200µg/hr. 
Albumin creatinine ratio :  2.5 – 25mg/mmol (for men) or
                                    3.5– 25 mg/mmol ( for women)
                                    30 - 300µg/ mg in both men and women.  
 The 24 hour urine collection is considered to be the gold standard for assessing 
the low levels of UAER.
Techniques of measurement and monitoring:
Timed urine collections 24 hor or overnight remain the gold std.  
Disadvantage:  This  is  cumbersome  to  the  patient,  in  repeated  large  scale 
screening,  this may become a significant  problem.  For large scale screening use of 
albumin creatinine ratio in early morning urine is a convenient and reliable screening 
method.  
Potential confounders:
Potential confounders in the detection of microalbuminuria are :
Day – to –day variation of 40%.  Several tests necessary. 
 False positives: Strenuous exercise, urinary tract infection,    menstruation severe 
of  dysregulation (newly diagnosed Type I  diabetes), 
 Urine WBC, Hematuria, Ischemic heart disease, Renal  disease.
Dipsticks exclusively detect albumin, sensitivity being for concentrations as low 
as 250 mg/ml.  All the below mentioned methods can be used for quantitative estimation 
of proteins, all the available methods are imperfect. Urine albumin cretatinine ratio can 
be used in random urine samples.  Measurements correlate well with those obtained by 
classical  way.  Urine albumin estimated by ELISA and creatinine by reaction – rate 
Kinetic principle RIA and Nephelometry.  
Methods for detecting and measuring proteinuria
Method Description Detection 
limit
Coments
Turbidimetric Addition of 
Trichloroacetic or 
sulfosalicylic acids after 
colloid properties and 
50 – 100 
mg/ml
Imprecise, 
different 
readings  for 
albumin  and 
produce turbidity to be 
read in densitometer 
(Benzathonium chloride 
also used)
globulin
Stick tests Impregnated with 
indicator dye 
(bromocresol green ) 
which changes colour in 
presence or protein.  
100mg/ml Reacts  poorly 
with  globulin. 
Usual   clinical 
screening test.  
Nephelometri
c 
Specific anti albumin 
antibody used. 
Measures 
albumin 
excretion,  not 
total protein.
Factors that Microalbuminuira helps to predict:
Diabetic renal disease
Diabetic Retinopathy
Complications in pregnancy
Cardiovascular mortality and morbidity in 
1. Type I diabetes
2. Type II Diabetes
3. Elderly Non diabetic people
4. Non diabetic people with hypertension
Association of Microalbuminuria with other cardiovascular risk factors:
There  are  several  reports  in  non  diabetic  population  of  an  association  between 
microalbuminuria and obesity, increased levels of LDL, plasma fibrinogen, increased 
alcohol consumption, cigarette smoking, high fat diet & low HDL. 
Microalbuminuria  may  reflect  a  prothrombotic  state  and  impaired  endothelial 
function  as  increased  levels  of  von  Willebrands  factor,  thrombodulin,  Thrombin  – 
antithrombin III complexes, and impaired fibrinolytic activity were described in subjects 
with  increased  UAER  (Mennen  et  al  2001).   These  derangements  may  lead  to 
augmented blood viscosity,  more peripheral  vascular  resistance,  there  by to increase 
UAER  and  to  diffuse  atherosclerotic  lesions.  It  is  suggested  that  microalbuminuria 
constitutes the renal manifestation of generalized vascular endothelial dysfunction that 
probably underlies the link between increased UAER and high risk for cardiovascular 
disease. (Pendrinelli et al 1999). 
Managing a case of Pre-Diabetes 
A diagnosis of pre-diabetes identifies an individual at high risk 
for developing type2 diabetes and increased risk of cardiovascular 
deaths.The treatment of pre-diabetes25 could alter the natural history of type 2 diabetes.
Lifestyle Interventions ;
Obesity is the most potent acquired risk factor for developing 
Type 2 diabetes.Studies have shown physical  inactivity26,low fibre  and high fat  diet 
increase future risk of diabetes. The Da Qing study demonstrated that community based 
diet and exercise reduced incident type 2 diabetes by 30-40% among Chinese subjects 
with IGT.The US Diabetes Prevention Progam(DPP) study
Founded that an intensive diet and exercise intervention reduced incident type 2 diabetes 
by 58%.
Pharmacological interventions;
The DPP study demonstrated that metformin decreased incident type2 diabetes by 31% 
relative to control.The STOP-NIDDM Trial  demonstrated that Acarbose treatment to 
IGT patients reduced incident type2 diabetes by 25%.The XENDOS Trial examined the 
use  of  Orlistat  in  obese  patients  ,decreased  incident  diabetes  by  37%.Recently  the 
DREAM trial shown reduction of type 2 diabetes by 60% using Rosiglitazone.Analysis 
of large no of trial of ACE or
ARB  could reduce risk by as much as 25%.
MATERIALS AND METHODS
The patients admitted in medical wards and those attending medical out patient 
unit  in Medical  College Hospital,  Coimbatore with a diagnosis of  Pre-diabetes  were 
studied during a period starting from May 2005 to October 2006.  
Number of study group         : One
Sample size          : 200
Study design         :  Prospective Analytical study
        Statistical method:       
Chi square test was used to study the relationship between microalbuminuria and 
other variables. P value was calculated for all the variables. For those variables with 
significant   P value, odds ratio was calculated.
Ethical concern:
The study conforms to the guidelines of declaration of Helsinki 1964, revised in 
1975.  The study was subjected to the ethical revision board of the study center.
 
Study Design:
Patients  over  30  years  of  age  who  was  diagnosed  to  have  Pre-diabetes  were 
included in the study, irrespective of the gender  
Exclusion criteria: 
1. Patients with age<30 years of age.
2. Patients with Hypertension(Blood Pressure >140/90mmHg)
3. Patients with Renal disease.
4. Patients with urinary tract infection by history or investigations.
5. Patients with raised serum creatinine [>1.5 mg/dl] or urine examination showing 
RBC, WBC, urine C & S yielding  bacteria.  
The diagnosis of Pre-diabetes was made by checking Fasting blood glucose,,ine FBS 
between 100-125 or OGTT between 140-199 are selected.FBS was taken after 8hrs over 
night fasting.OGTT done using 75 gram of glucose.
1. Both out-patients and in-patients are included.  
2. A  detailed case record was prepared for each patient on the basis of specially 
designed proof.           
3.   The study population was divided into two groups depending on Fasting blood 
sugar{FBS} or IFG and 2hour Oral Glucose tolerance test(OGT) or IGT.
1. IFG  100 – 109                1.IGT  140-159
2. IFG  110- 119                  2.IGT  160-179
3. IFG  120–125                  3.IGT   180-199
This was an arbitrary division done for the ease of comparison.
  
Fundus  Examination:  Done  by  direct  ophthalmoscopy;  pupillary  dilatation  achieved 
using 1% Tropicamide.  According to Fundus findings, the patients were divided into 6 
groups. (Refer to Review of Literature):
1. Fundus normal 
2. Fundus not visualised
3. Mild Non-proliferative Diabetic Retinopathy 
4. Moderate Non-proliferative Diabetic Retinopathy
5. Severe Non-proliferative Diabetic Retinopathy
6. Proliferative Diabetic Retinopathy
Investigations done included:
1. Fasting blood sugar,2Hour Oral Glucose Tolerance Test
2. Serum creatinine – Only those patients with normal value were taken up for the 
study.
3. Urine examination – Albumin, RBC, WBC, Bacteria, Urine culture, ketones.  Only 
those  patients  with  normal  urine  examinationresults  were  included. 
Microalbuminuria:
    Was  assessed  by  urine  albumin:  creatinine  ratio  (ACR)  based    on  the 
recommendations of National Kidney Foundation and American Diabetic Association. 
The average of the ACR values from 3 urine samples were used. Urine  albumin  was 
estimated   by   turbidimetry.  1st voided  midstream  early  morning  sample  of  5ml 
urine.Patients were asked to avoid exercise prior to collection, urine examination done 
in women in non menstrual phase.  
Any value in between 30 – 300 µg/mg creatinine was taken as microalbuminuria.  
Sex specific ACR cut off points: > 17µg/mg in men          Sex specific ACR cut 
off points : > 25 µg/mg in women.
 
OBSERVATIONS
A total of 200 Pre-diabetic patients were studied.
Out patients -   132
In patients  -    68
Table No:1 – Age Distribution
Age in years No of patients Percentage
30 – 39 26 13
40 – 49 36 18
50 – 59 59 29.5
60 – 69 68 34
70 – 79 11 5.5
Table No:2 – Sex Distribution
Sex No. of Percentage
patients
Male 116 58
Female 84 42
Table No:3 - Distribution of microalbuminuria among males & females
Microalbuminuria 
Absent Present
No. % No. %
Sex Male   102 89.5 12 10.5
Female 76 90.5 8 9.5
χ2 = .05
P = .
81(Non 
significant)
There was no statistically significant difference in the prevalence of microalbuminuria in 
male & female pre-diabetics( P=0.81). 
Table no:4-Distribution of Microalbuminuria in IFG and IGT.
Absent
no %
IFG 10
9
94%
IGT 75 85%
Microalbuminuria 
Absent Present
No. % No. %
χ2
=4.83
P=.02
IFG 109   94% 7 6%
IGT 71 84.5%    13 15.5%
There is increased prevalence of microalbuminuria in IGT when
Compared to IFG, and it is statistically significant( P=0.02)
   
Table No:5–Distribution of microalbuminuria among different age groups
Age (years) Microalbuminuria 
Absent Present
No % No %
30 – 39 25 92.3 1    7.7
40 – 49 37 91.6 3    8.3
50 – 59     52 91.5 7    8.4
60 – 69 58 91.1 8    8.8
70 – 79 7 90.9 1    9
 χ2 =1.98
P =0.74
     
It was observed that as the age advances,there is no statisticallysignificant increase in 
microalbuminuria.  
Table No:6 – Distribution of microalbuminuria among smokers &non smokers
Smoking Total 
No:
Microalbuminuria 
Absent Present
No. % No. %
Nonsmoker 107 96 91.6 11 8.4
Smoker 93 84 91.4 9 8.6
  χ2  =0.02
P=0.88
There  was  no  statistically  significant  difference  among  the  prevalence  of 
microalbuminuria among smokers & non smokers. 
Table No:7 – Microalbuminuria & the level of blood sugar in IFG
    IFG
Microalbuminuria 
Absent Present
No % No %
100-109 68 98.6 1 1.4
110-119 27   90 3 10
 120-125      14 82.4      3 17.6
χ2 = 
6.31
P<0.05
The prevalence of microalbuminuria increases with increase in blood sugar in the pre-
diabetic range and it is statisticaiiy significant(P value<0.05)
Tableno:8-Microalbuminuria and levels of blood sugar in IGT
IGT 
Microalbuminuria 
Absent Present
No % No %
140-159 42 93.3 3 6.7
160-179 18 78.3 5 21.7
180-199 11 68.8 5 31.2
χ2 = 
6.4
P=.04
The prevalence of microalbuminuria increases as the blood sugar 
raises in the pre-diabetic range in IGT and it is statistically significant(P value=0.04).
Table no:8-Distribution of retinopathy in males and females
 
 Sex
Retinopathy                
Absent Present 
   No.   %  No    %
 male    108  92.2   8 7.8
female     79  92.9    5 7.1
χ2 
=0.07
P=.78
It was observed that there was no statistically significant difference in prevalence of 
retinopathy in male and female pre-diabetic.
Table no:9-Distribution of retinopathy in different age groups.
Retinopathy
Age Absent Present
No. % No %
30-39 25 96.2 1 3.8
40-49 34 97.1 1 2.9
50-59 54 93.1 4 6.9
60-69 62 91.1 6 8.8
70-79 10 90.9 1 9.1
       
χ2
  
=1.79
P=0.77
As the age advances there is no statistically increase in prevalence of retinopathy.
Table no:10-Retinopathy and levels of blood sugar in IFG
IFG
Retinopathy
Absent Present
No % No %
100-109 52 100 0 0
`110-119 37 47.6 1 52.4
120-125 23 82.2 3 17.8
χ2 = 7.04
P = 0.029
The prevalence of retinopathy increase as the blood sugar rises within the pre-diabetic 
range in IFG and it is statistically significant.
 Table no:12- Retinopathy and levels of blood sugar in IGT
IGT
Microalbuminuria 
Absent Present
No % No %
140-159 29 100 0 0
160-179 27 87.1 4 12.9
180-199 19 79.1 5 20.8
χ2 = 12.4
P = 0.001
There  is  increase  in  prevalence  of  retinopathy  as  the  blood  sugar  rises  within  pre-
diabetic range in IGT and it is statistically significant.
.
Table no:13-Microalbuminuria and retinopathy changes 
Fundus Total 
No: of 
cases
Microalbuminuria 
Absent Present
No % No. %
Normal 165 159 96.4 7 3.6
MildNPDR 11 4 41.7 7 58.3
Moderate.NPDR 2 0 33.3 2 66.7
Severe.NPDR 0
PDR 0
χ2 =65.35
P < 0.0001
A  higher  proportion  of  patients  with  early  diabetic  retinopathy  had 
microalbuminuria  compared  to  those  with  out  retinopathy  changes.  the  association 
between the two were statistically significant.[ P<0.0001] 
Abnormalities in Fundus Examination:
13 patients had the changes of Diabetic Retinopathy.  
165 patients had normal fundus.
20 patients fundus not visualized( due to hazy media).
9 patients had associated microalbuminuria(69.2%)
4 patients had no microalbuminuria(30.8%)
                          
                         DISCUSSION
The present study evaluated the prevalence of microalbuminuria and retinopathy 
in  pre-diabetic  patients  and  correlation  between  microalbuminuria,retinopathy  with 
age,smoking and aiso levels of fasting blood sugar and OGTT.  
   Prevalence :  The prevalence of microalbuminuria in this  study was 10% and that of 
retinopathy  was  6.5%.The  prevalence  of  microalbuminuria  is  more  in  IGT(15.5%) 
compared  to  IFG(6%).A  similiar  study  by  WangXL  etal  showed  a  prevalence  of 
microalbuminuria as 11.1% in IGT and 5.8 % in IFG.When the blood sugar rises in the 
pre-diabetic range in IFG and IGT the prevalence of microalbuminuria also rises. The 
prevalence of retinopathy was  also more in IGT(12%) compared to IFG(3-6%).The 
prevalence was higher in those with higher blood sugar both in IFG and IGT.The DPP 
Outcome Study(Diabetes Prevention Program) showed a prevalence of retinopathy as 
7.6% in those with pre-diabetes  using  Fasting blood glucose.A higher  proportion of 
patients  with  retinopathy  had  microalbuminuria  and  association  prevalence  was 
statistically significant.
 Sex distribution of microalbuminuria and retinopathy: In the present study, for both 
microalbuminuria and retinopathy there was no significant difference  of prevalence   in 
men and women. In the HUNT study (Norway) a stronger association was observed 
between  microalbuminuria and mortality in men than in women.   In this  study the 
interaction between sex and Albumin creatinine Ratio (ACR) was statistically significant 
(p=  0.003)  and  supported  a  sex   difference,  women  had  more  prevalence.   They 
attributed this difference to the higher incidence of asymptomatic UTI in women.  They 
suggested the need for different ACR cut off values in men and women – because men 
have greater muscle mass and higher creatinine excretion than women although albumin 
excretion levels are equal13.  (HUNT – Nord Trondelag Health Study).    
The prevalence of microalbuminuria and retinopathy was   not statistically higher in the 
older  age  groups.The  present  study  also  looked  into  the  relation  between 
microalbuminuria  and  other  risk  factors  for  cardiovascular  disease  like  smoking.No 
significant  correlation  was  observed between smoking and microalbuminuria..   This 
observation is discordant with that seen in previous studies on this aspect.  One possible 
explanation for this variability – may be an error in the classification of smokers and non 
smokers – this was done on the basis of history.  
CONCLUSIONS
1.Pre-diabetes is a mounting health problem in the community early diagnosis and 
intervention  delay  the  onset  of  diabetes   and  the  microvascular  complications. 
     
2.The microvascular complications like retinopathy and microalbuminuria starts in 
the pre-diabetic stage itself.     
 3.Prevalence of microalbuminuria and retinopathy was more in IGT when compared 
to IFG.
4.There is significant correlation between microalbuminuria and retinopathy in pre-
diabetic patients.
5.The IGT is more important cardiovascular risk factor than IFG .
6.Further studies including large population are needed to know the prevalence of 
retinopathy and microalbuminuria in pre-diabetic individuals.
.       
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